Identification of a low‐risk group of stage I breast cancer patients by cytometrically assessed DNA and nuclear texture parameters

Image cytometrical measurements were performed on Feulgen‐stained cells from 329 stage I breast cancers (pT1pN0,M0,R0). For each patient, several DNA (ploidy, S‐phase fraction, exceeding rates, 2c deviation index, ploidy balance, entropy, and histogram typing), morphometric (area and radius of nuclei), and textural parameters (mainly co‐occurrence and run‐length) were calculated. The prognostic value of these parameters was investigated by multivariate Cox regression analysis, considering a distant recurrence‐free survival of 8 years as the prognostic criterion. In the multivariate analysis, one DNA parameter (histogram type) and two textural parameters (co‐occurrence and variation of the average heterochromatin area) were proven to have independent prognostic value. Using a linear combination of these variables, a prognostic factor was calculated for each individual patient. Patients were stratified using this factor into several groups according to their risk for distant recurrence. Thus, a low‐risk group of stage I patients was identified, remaining distant recurrence‐free for 8 years. In addition, a group of patients with a worse prognosis and an 8‐year recurrence rate of about 26 per cent was identified, compared with the average distant recurrence rate of all stage I patients of 13 per cent. A combination of DNA and textural parameters can provide powerful prognostic information in stage I breast carcinomas and may allow a better selection of patients for different therapy protocols.

[1]  G. Auer,et al.  Prognostic significance of dna measurements in 409 consecutive breast cancer patients , 1988, Cancer.

[2]  H. Joensuu,et al.  Identification of subgroups with favorable prognosis in breast cancer. , 1992, Acta oncologica.

[3]  I. P. Corbett,et al.  Predicting outcome for patients with node negative breast cancer: a comparative study of the value of flow cytometry and cell image analysis for determination of DNA ploidy. , 1992, British Journal of Cancer.

[4]  Donald E. Henson,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989 .

[5]  G. Auer,et al.  Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. A retrospective study of 227 consecutive cases , 1988, Cancer.

[6]  C. Souchier,et al.  An image cytometric DNA-analysis in breast neoplasms. Parameters of DNA-aneuploidy and their relationship with conventional prognostic factors. , 1992, Pathology, research and practice.

[7]  M Oberholzer,et al.  Cytometry in histological sections of colon carcinoma. , 1992, Pathology, research and practice.

[8]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[9]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[10]  I. Christensen,et al.  Flow cytometric DNA ploidy defines patients with poor prognosis in node‐negative breast cancer , 2007, International journal of cancer.

[11]  D Komitowski,et al.  Quantitative features of chromatin structure in the prognosis of breast cancer , 1990, Cancer.

[12]  M. Fernö,et al.  Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry. , 1992, Cytometry.

[13]  T. Caspersson,et al.  Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans. , 1984, Cancer research.

[14]  M. Fernö,et al.  Indicators of prognosis in node-negative breast cancer. , 1990, The New England journal of medicine.

[15]  G. Brugal,et al.  Cytometry of breast carcinoma: significance of ploïdy balance and proliferation index. , 1987, Cytometry.

[16]  A. Rademaker,et al.  Dna flow cytometry and pathologic grading as prognostic guides in axillary lymph node‐negative breast cancer , 1993, Cancer.

[17]  J. Baak,et al.  Limited prognostic value of cellular DNA content to classical and morphometrical parameters in invasive ductal breast cancer. , 1988, American journal of clinical pathology.

[18]  O. Kallioniemi,et al.  Prognostic value of cells with more than 5c DNA content in node-negative breast cancer as determined by image cytometry from tissue sections. , 1993, Human Pathology.

[19]  H. Joensuu,et al.  Prognosis of breast cancer with small primary tumor (pT1). , 1991, Acta oncologica.

[20]  M Aubele,et al.  Interactive cytometry, chance or evil of bias? , 1992, Pathology, research and practice.

[21]  E. Jarasch,et al.  Quantitative aspects in defining prognostic factors of breast cancer. , 1989, Pathology, Research and Practice.

[22]  K Rodenacker Invariance of textural features in image cytometry under variation of size and pixel magnitude. , 1995, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[23]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[24]  K Rodenacker,et al.  Problems concerning the quality of DNA measurements on Feulgen-stained imprints. A study of five fixation techniques. , 1994, Analytical and quantitative cytology and histology.

[25]  R. Blamey,et al.  A prognostic index in primary breast cancer. , 1982, British Journal of Cancer.

[26]  V. Kosma,et al.  DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer , 1992, International journal of cancer.

[27]  Mary M. Galloway,et al.  Texture analysis using gray level run lengths , 1974 .

[28]  J. Baak,et al.  The Multivariate Prognostic Index and nuclear DNA content are independent prognostic factors in primary breast cancer patients. , 1989, Cytometry.

[29]  J. Winstanley,et al.  Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer. , 1992, British Journal of Cancer.

[30]  J. Baak,et al.  The value of morphometry to classic prognosticators in breast cancer , 1985, Cancer.